KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY;MEDICINAL BIOCONVERGENCE RESEARCH CENTER
发明人:
Myung Hee Kim,Eun Young Lee,Sung Hoon Kim,Chul Ho Lee
申请号：
US16283121
公开号：
US20190321455A1
申请日:
2019.02.22
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention relates to an EPRS (glutamyl-prolyl-tRNA synthetase) protein or a fragment thereof.The EPRS protein of the present invention or fragment thereof may bind to PCBP2 protein to activate the MAVS signaling pathway, and thus it has anti-RNA viral effects, thereby being effective for preventing or treating a RNA viral infectious disease.
